The Endovascular Engineering ENGULF Study is testing a new tool called the Hēlo PE Thrombectomy System to help remove blood clots in the lungs, known as a pulmonary embolism (PE). A PE happens when a blood clot blocks blood flow to the lungs, which can be serious. This study is for adults aged 18 to 90 who have a specific type of PE that isn't too severe.
To join, patients must have recent signs of PE, like trouble breathing, and meet certain health conditions. They must also sign a consent form. Some people can't join if they have had a very severe PE, other recent blood clots, or certain health conditions like high blood pressure in the lungs, low red blood cell count, or severe heart issues.
- Study involves a procedure using a special medical device.
- Participants must meet specific health criteria.
- Consent is needed to join, and certain risks may apply.
Participants should discuss with their doctor to see if they qualify and understand the benefits and risks before deciding to join.